Digital diagnosis and treatment system for sarcopenia
Official title: Establishment and Application of a Digital Diagnosis and Treatment System for Sarcopenia
Run by Peking Union Medical College Hospital · NCT06380777 · Data updated 2026-11-12
This study is testing a new digital system to help diagnose and treat sarcopenia in people aged 45 and older by providing early screening, medication, and rehabilitation programs tailored to their needs.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 45 Years and up |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | Peking Union Medical College Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | September 1, 2023 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | April 24, 2024 |
| Trial ID | NCT06380777 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 45 and older who meet the diagnostic criteria for sarcopenia.
✕Probably not a fit
Patients under 45 years old or those with acute chronic illnesses or cognitive impairments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to establish a comprehensive digital system for diagnosing and treating sarcopenia. It integrates a digital vaccine for early screening, a digital drug for intervention, and a digital rehabilitation program for prevention. Participants aged 45 and older will be screened and monitored longitudinally, receiving tailored interventions based on their condition. The study seeks to create a visual tertiary prevention network to effectively manage sarcopenia.
Why it matters
Potential benefit: If successful, this approach could significantly improve early detection and management of sarcopenia, enhancing patient outcomes.
How similar studies have gone: While the integration of digital tools in managing sarcopenia is innovative, similar approaches in other conditions have shown promise, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥45 years; * meeting sarcopenia diagnostic criteria; * consent to participate in this study Exclusion Criteria: * Age \<45 years; * patients in acute phase of chronic illness; * infectious disease patients; * people who lack of independent mobility; * people who lack of communication or cognitive skills; * people who refusal to participate in this study
Where it's running
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Yu Kang
- Email: yuk1997@sina.com
- Phone: 86 13801130457
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sarcopenia in Patients After Cardiac Surgery
This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.
-
Bone marrow mesenchymal stem cell injection for sarcopenia
This study tests whether CG-BM1, a stem cell injection, can be safely given to adults with sarcopenia to see if it helps improve muscle health.
-
GLP-1 receptor agonist use and muscle health in adults with obesity without diabetes
This study tests whether GLP-1 receptor agonists affect muscle mass and strength in adults with obesity who don’t have diabetes.
-
Sarcopenia and Epidural Steroid Injections in Lumbar Spinal Stenosis
We’re testing how sarcopenia relates to pain, function, and quality of life after a routine interlaminar epidural steroid injection in people with lumbar spinal stenosis.
-
Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients
This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.
-
Lower-limb rehabilitation robot training with nutrition education for sarcopenia
In adults aged 60 and older with sarcopenia, this study tests whether adding robot-assisted leg training to nutrition education can improve muscle mass and walking ability compared with usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.